ADC conjugation, redefined. Explore a rapid 3-hour workflow that delivers precise, controlled antibody-drug conjugates for ...
Amid a wave of leadership transitions in biopharma, ADC Therapeutics is the latest drugmaker to shake up its management. On Monday, the company said co-founder Chris Martin is stepping back from his ...
Samsung Bioepis has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for a phase 1 clinical trial of an antibody-drug conjugate (ADC) new drug ...
8d
Operationalizing ADC Clinical Trials: Best Practices for Success, Upcoming Webinar Hosted by Xtalks
As the oncology landscape evolves, antibody-drug conjugates (ADCs) have emerged as one of the most promising modalities in ...
Antibody drug conjugates, or ADCs, are picking up momentum. Of the 11 drugs in this class that have been approved by the FDA, six have reached the market in the last two years. Meanwhile, new ADC ...
Samsung Life Science Fund, created jointly by Samsung Biologics Co. Ltd., Samsung Biopeis Co. Ltd. and Samsung C&T Corp., said it invested in Waltham, Mass.-based antibody-drug conjugate (ADC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback